nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRNB2—SIDS Susceptibility Pathways—FEV—coronary artery disease	0.00347	0.0253	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CAV3—coronary artery disease	0.00263	0.0192	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—RAI1—coronary artery disease	0.00241	0.0176	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—FEV—coronary artery disease	0.00237	0.0173	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—BHLHE40—coronary artery disease	0.00199	0.0145	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—FEV—coronary artery disease	0.00193	0.0141	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.00182	0.0133	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.00182	0.0133	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CAV3—coronary artery disease	0.0018	0.0131	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.00171	0.0125	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—BHLHE40—coronary artery disease	0.00163	0.0119	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—RYR2—coronary artery disease	0.00159	0.0116	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—ID3—coronary artery disease	0.00155	0.0113	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.00151	0.011	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.00151	0.011	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CREM—coronary artery disease	0.00149	0.0108	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CAV3—coronary artery disease	0.00146	0.0107	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—BHLHE40—coronary artery disease	0.00136	0.00993	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.00131	0.00955	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—KCNJ8—coronary artery disease	0.0013	0.00948	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.00129	0.00938	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.00128	0.00936	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.00124	0.00908	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.00124	0.00908	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—NRIP1—coronary artery disease	0.00118	0.00858	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.00115	0.00841	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—KCNJ8—coronary artery disease	0.00114	0.00835	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.00113	0.00826	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—UTS2R—coronary artery disease	0.00113	0.00822	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.00112	0.00815	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—BHLHE40—coronary artery disease	0.00111	0.00809	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—RYR2—coronary artery disease	0.00109	0.00794	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—ADORA1—coronary artery disease	0.00109	0.00792	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.00108	0.00791	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.00106	0.00771	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.00103	0.00752	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.00103	0.0075	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.00103	0.00748	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.00101	0.0074	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.00101	0.0074	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.00101	0.00735	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—ARNTL—coronary artery disease	0.000985	0.00719	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—KCNJ2—coronary artery disease	0.000985	0.00718	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000984	0.00718	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000942	0.00687	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—UTS2—coronary artery disease	0.000891	0.0065	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000887	0.00647	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—RYR2—coronary artery disease	0.000887	0.00647	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.000877	0.0064	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—KCNJ2—coronary artery disease	0.000867	0.00633	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000866	0.00632	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000861	0.00628	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.000841	0.00613	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.000839	0.00612	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.00083	0.00605	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000828	0.00604	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—KCNJ8—coronary artery disease	0.000824	0.00601	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.000815	0.00594	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.000787	0.00574	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—KCNJ8—coronary artery disease	0.000782	0.0057	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.000773	0.00564	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.000763	0.00557	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000758	0.00553	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000758	0.00553	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—PLCB3—coronary artery disease	0.000754	0.0055	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000753	0.00549	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CST3—coronary artery disease	0.000752	0.00549	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000729	0.00532	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.000722	0.00527	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.000715	0.00522	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.000701	0.00511	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000698	0.00509	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—F7—coronary artery disease	0.000675	0.00493	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000667	0.00487	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—PLCB3—coronary artery disease	0.000664	0.00484	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000648	0.00472	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000644	0.0047	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.000642	0.00468	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000639	0.00466	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—KCNJ8—coronary artery disease	0.000637	0.00465	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—ALDH2—coronary artery disease	0.000635	0.00463	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.00063	0.0046	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—KCNJ2—coronary artery disease	0.000624	0.00455	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000624	0.00455	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.000622	0.00454	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000622	0.00453	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000606	0.00442	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—KCNJ2—coronary artery disease	0.000592	0.00432	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000592	0.00432	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.000589	0.00429	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—ADIPOQ—coronary artery disease	0.000583	0.00425	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000581	0.00424	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—CAMK2D—coronary artery disease	0.00058	0.00423	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.000572	0.00417	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.00057	0.00416	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—ALDH2—coronary artery disease	0.000559	0.00408	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—HTR7—coronary artery disease	0.000556	0.00406	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000546	0.00398	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000542	0.00395	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000539	0.00393	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000525	0.00383	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000525	0.00383	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000524	0.00382	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000518	0.00378	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000515	0.00375	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—CAMK2D—coronary artery disease	0.000511	0.00373	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000498	0.00364	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—PLCB1—coronary artery disease	0.000496	0.00362	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000494	0.00361	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—KCNJ2—coronary artery disease	0.000483	0.00352	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000483	0.00352	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.00048	0.0035	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—PLCB3—coronary artery disease	0.000478	0.00349	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000477	0.00348	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000477	0.00348	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PPARGC1A—coronary artery disease	0.000474	0.00346	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	0.000472	0.00344	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SIRT1—coronary artery disease	0.000459	0.00335	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000456	0.00332	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.000454	0.00331	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—PLCB3—coronary artery disease	0.000454	0.00331	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—PLCB1—coronary artery disease	0.000437	0.00319	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000425	0.0031	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000422	0.00308	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000419	0.00306	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	0.000415	0.00303	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000411	0.003	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000406	0.00296	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—ALDH2—coronary artery disease	0.000402	0.00294	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000397	0.0029	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.00039	0.00284	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000389	0.00284	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—ALDH2—coronary artery disease	0.000382	0.00279	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.000381	0.00278	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000372	0.00271	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000372	0.00271	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.00037	0.0027	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—PLCB3—coronary artery disease	0.00037	0.0027	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000368	0.00269	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—CAMK2D—coronary artery disease	0.000368	0.00268	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—LEP—coronary artery disease	0.000362	0.00264	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000358	0.00261	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.000355	0.00259	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—CAMK2D—coronary artery disease	0.000349	0.00255	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000346	0.00253	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—NOS2—coronary artery disease	0.000337	0.00246	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000326	0.00238	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000324	0.00236	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000318	0.00232	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PPARG—coronary artery disease	0.000315	0.0023	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—PLCB1—coronary artery disease	0.000315	0.00229	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—GSK3B—coronary artery disease	0.000314	0.00229	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.000312	0.00228	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—ALDH2—coronary artery disease	0.000311	0.00227	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CREB1—coronary artery disease	0.000311	0.00227	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.00031	0.00226	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000302	0.0022	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.0003	0.00219	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	0.000299	0.00218	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—PLCB1—coronary artery disease	0.000299	0.00218	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.000295	0.00215	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000292	0.00213	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—CAMK2D—coronary artery disease	0.000285	0.00208	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SERPINE1—coronary artery disease	0.000284	0.00207	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	0.000284	0.00207	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000283	0.00206	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000282	0.00206	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—CREB1—coronary artery disease	0.000272	0.00198	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	0.000267	0.00195	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000266	0.00194	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.00026	0.0019	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000254	0.00185	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.000253	0.00185	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—PLCB1—coronary artery disease	0.000243	0.00178	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	0.000239	0.00175	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—CREB1—coronary artery disease	0.000239	0.00175	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	0.000235	0.00171	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	0.000231	0.00169	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.000225	0.00164	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.000213	0.00156	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.000212	0.00155	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000207	0.00151	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—TNF—coronary artery disease	0.000205	0.0015	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.000201	0.00147	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—MAPK1—coronary artery disease	0.000201	0.00146	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000193	0.00141	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000193	0.00141	CbGpPWpGaD
Varenicline—Abdominal pain—Captopril—coronary artery disease	0.00019	0.00022	CcSEcCtD
Varenicline—Body temperature increased—Captopril—coronary artery disease	0.00019	0.00022	CcSEcCtD
Varenicline—Dizziness—Simvastatin—coronary artery disease	0.000189	0.000219	CcSEcCtD
Varenicline—Rash—Ezetimibe—coronary artery disease	0.000189	0.000219	CcSEcCtD
Varenicline—Dermatitis—Ezetimibe—coronary artery disease	0.000189	0.000219	CcSEcCtD
Varenicline—Discomfort—Timolol—coronary artery disease	0.000189	0.000219	CcSEcCtD
Varenicline—Asthenia—Niacin—coronary artery disease	0.000188	0.000218	CcSEcCtD
Varenicline—Fatigue—Losartan—coronary artery disease	0.000188	0.000218	CcSEcCtD
Varenicline—Headache—Ezetimibe—coronary artery disease	0.000188	0.000218	CcSEcCtD
Varenicline—Malaise—Lisinopril—coronary artery disease	0.000188	0.000217	CcSEcCtD
Varenicline—Oedema—Ramipril—coronary artery disease	0.000187	0.000217	CcSEcCtD
Varenicline—Vertigo—Lisinopril—coronary artery disease	0.000187	0.000217	CcSEcCtD
Varenicline—Dry mouth—Timolol—coronary artery disease	0.000187	0.000216	CcSEcCtD
Varenicline—Pain—Losartan—coronary artery disease	0.000187	0.000216	CcSEcCtD
Varenicline—Constipation—Losartan—coronary artery disease	0.000187	0.000216	CcSEcCtD
Varenicline—Syncope—Lisinopril—coronary artery disease	0.000187	0.000216	CcSEcCtD
Varenicline—Vomiting—Eplerenone—coronary artery disease	0.000187	0.000216	CcSEcCtD
Varenicline—Feeling abnormal—Furosemide—coronary artery disease	0.000186	0.000216	CcSEcCtD
Varenicline—Nausea—Fenofibrate—coronary artery disease	0.000186	0.000215	CcSEcCtD
Varenicline—Pruritus—Niacin—coronary artery disease	0.000186	0.000215	CcSEcCtD
Varenicline—Asthenia—Pravastatin—coronary artery disease	0.000185	0.000215	CcSEcCtD
Varenicline—Gastrointestinal pain—Furosemide—coronary artery disease	0.000185	0.000214	CcSEcCtD
Varenicline—Rash—Eplerenone—coronary artery disease	0.000185	0.000214	CcSEcCtD
Varenicline—Urticaria—Perindopril—coronary artery disease	0.000185	0.000214	CcSEcCtD
Varenicline—Hypersensitivity—Trandolapril—coronary artery disease	0.000185	0.000214	CcSEcCtD
Varenicline—Dermatitis—Eplerenone—coronary artery disease	0.000185	0.000214	CcSEcCtD
Varenicline—Diarrhoea—Valsartan—coronary artery disease	0.000185	0.000214	CcSEcCtD
Varenicline—Shock—Ramipril—coronary artery disease	0.000184	0.000213	CcSEcCtD
Varenicline—Hypersensitivity—Enalapril—coronary artery disease	0.000184	0.000213	CcSEcCtD
Varenicline—Body temperature increased—Perindopril—coronary artery disease	0.000184	0.000213	CcSEcCtD
Varenicline—Abdominal pain—Perindopril—coronary artery disease	0.000184	0.000213	CcSEcCtD
Varenicline—Palpitations—Lisinopril—coronary artery disease	0.000184	0.000213	CcSEcCtD
Varenicline—Diarrhoea—Olmesartan—coronary artery disease	0.000184	0.000213	CcSEcCtD
Varenicline—Headache—Eplerenone—coronary artery disease	0.000184	0.000213	CcSEcCtD
Varenicline—Nervous system disorder—Ramipril—coronary artery disease	0.000184	0.000213	CcSEcCtD
Varenicline—Thrombocytopenia—Ramipril—coronary artery disease	0.000183	0.000212	CcSEcCtD
Varenicline—Oedema—Timolol—coronary artery disease	0.000183	0.000212	CcSEcCtD
Varenicline—Pruritus—Pravastatin—coronary artery disease	0.000183	0.000212	CcSEcCtD
Varenicline—Loss of consciousness—Lisinopril—coronary artery disease	0.000183	0.000212	CcSEcCtD
Varenicline—Nausea—Clopidogrel—coronary artery disease	0.000183	0.000212	CcSEcCtD
Varenicline—Tachycardia—Ramipril—coronary artery disease	0.000183	0.000212	CcSEcCtD
Varenicline—Skin disorder—Ramipril—coronary artery disease	0.000182	0.000211	CcSEcCtD
Varenicline—Infection—Timolol—coronary artery disease	0.000182	0.000211	CcSEcCtD
Varenicline—Vomiting—Simvastatin—coronary artery disease	0.000182	0.000211	CcSEcCtD
Varenicline—Hypersensitivity—Telmisartan—coronary artery disease	0.000182	0.000211	CcSEcCtD
Varenicline—Cough—Lisinopril—coronary artery disease	0.000182	0.00021	CcSEcCtD
Varenicline—Nausea—Lovastatin—coronary artery disease	0.000182	0.00021	CcSEcCtD
Varenicline—Hyperhidrosis—Ramipril—coronary artery disease	0.000181	0.00021	CcSEcCtD
Varenicline—Rash—Simvastatin—coronary artery disease	0.00018	0.000209	CcSEcCtD
Varenicline—Dermatitis—Simvastatin—coronary artery disease	0.00018	0.000209	CcSEcCtD
Varenicline—Asthenia—Trandolapril—coronary artery disease	0.00018	0.000209	CcSEcCtD
Varenicline—Shock—Timolol—coronary artery disease	0.00018	0.000209	CcSEcCtD
Varenicline—Feeling abnormal—Losartan—coronary artery disease	0.00018	0.000209	CcSEcCtD
Varenicline—Urticaria—Furosemide—coronary artery disease	0.00018	0.000208	CcSEcCtD
Varenicline—Diarrhoea—Niacin—coronary artery disease	0.00018	0.000208	CcSEcCtD
Varenicline—Nervous system disorder—Timolol—coronary artery disease	0.00018	0.000208	CcSEcCtD
Varenicline—Asthenia—Enalapril—coronary artery disease	0.000179	0.000208	CcSEcCtD
Varenicline—Headache—Simvastatin—coronary artery disease	0.000179	0.000208	CcSEcCtD
Varenicline—Abdominal pain—Furosemide—coronary artery disease	0.000179	0.000207	CcSEcCtD
Varenicline—Body temperature increased—Furosemide—coronary artery disease	0.000179	0.000207	CcSEcCtD
Varenicline—Gastrointestinal pain—Losartan—coronary artery disease	0.000179	0.000207	CcSEcCtD
Varenicline—Dizziness—Valsartan—coronary artery disease	0.000179	0.000207	CcSEcCtD
Varenicline—Anorexia—Ramipril—coronary artery disease	0.000178	0.000207	CcSEcCtD
Varenicline—Nausea—Ezetimibe—coronary artery disease	0.000178	0.000206	CcSEcCtD
Varenicline—Skin disorder—Timolol—coronary artery disease	0.000178	0.000206	CcSEcCtD
Varenicline—Dizziness—Olmesartan—coronary artery disease	0.000178	0.000206	CcSEcCtD
Varenicline—Pruritus—Trandolapril—coronary artery disease	0.000178	0.000206	CcSEcCtD
Varenicline—Chest pain—Lisinopril—coronary artery disease	0.000177	0.000205	CcSEcCtD
Varenicline—Myalgia—Lisinopril—coronary artery disease	0.000177	0.000205	CcSEcCtD
Varenicline—Arthralgia—Lisinopril—coronary artery disease	0.000177	0.000205	CcSEcCtD
Varenicline—Hyperhidrosis—Timolol—coronary artery disease	0.000177	0.000205	CcSEcCtD
Varenicline—Asthenia—Telmisartan—coronary artery disease	0.000177	0.000205	CcSEcCtD
Varenicline—Pruritus—Enalapril—coronary artery disease	0.000177	0.000205	CcSEcCtD
Varenicline—Diarrhoea—Pravastatin—coronary artery disease	0.000177	0.000205	CcSEcCtD
Varenicline—CHRNB2—Transmission across Chemical Synapses—MAPK1—coronary artery disease	0.000177	0.00129	CbGpPWpGaD
Varenicline—Anxiety—Lisinopril—coronary artery disease	0.000177	0.000205	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000176	0.000204	CcSEcCtD
Varenicline—Discomfort—Lisinopril—coronary artery disease	0.000175	0.000203	CcSEcCtD
Varenicline—Hypotension—Ramipril—coronary artery disease	0.000175	0.000203	CcSEcCtD
Varenicline—Anorexia—Timolol—coronary artery disease	0.000174	0.000202	CcSEcCtD
Varenicline—Pruritus—Telmisartan—coronary artery disease	0.000174	0.000202	CcSEcCtD
Varenicline—Nausea—Eplerenone—coronary artery disease	0.000174	0.000202	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.000174	0.00127	CbGpPWpGaD
Varenicline—Dizziness—Niacin—coronary artery disease	0.000174	0.000201	CcSEcCtD
Varenicline—Urticaria—Losartan—coronary artery disease	0.000173	0.000201	CcSEcCtD
Varenicline—Dry mouth—Lisinopril—coronary artery disease	0.000173	0.000201	CcSEcCtD
Varenicline—Abdominal pain—Losartan—coronary artery disease	0.000173	0.0002	CcSEcCtD
Varenicline—Body temperature increased—Losartan—coronary artery disease	0.000173	0.0002	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—CREB1—coronary artery disease	0.000172	0.00126	CbGpPWpGaD
Varenicline—Asthenia—Captopril—coronary artery disease	0.000172	0.000199	CcSEcCtD
Varenicline—Diarrhoea—Trandolapril—coronary artery disease	0.000172	0.000199	CcSEcCtD
Varenicline—Vomiting—Valsartan—coronary artery disease	0.000172	0.000199	CcSEcCtD
Varenicline—Diarrhoea—Enalapril—coronary artery disease	0.000171	0.000198	CcSEcCtD
Varenicline—Hypotension—Timolol—coronary artery disease	0.000171	0.000198	CcSEcCtD
Varenicline—Dizziness—Pravastatin—coronary artery disease	0.000171	0.000198	CcSEcCtD
Varenicline—Vomiting—Olmesartan—coronary artery disease	0.000171	0.000198	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000171	0.000198	CcSEcCtD
Varenicline—Rash—Valsartan—coronary artery disease	0.00017	0.000197	CcSEcCtD
Varenicline—Dermatitis—Valsartan—coronary artery disease	0.00017	0.000197	CcSEcCtD
Varenicline—Nausea—Simvastatin—coronary artery disease	0.00017	0.000197	CcSEcCtD
Varenicline—Oedema—Lisinopril—coronary artery disease	0.00017	0.000197	CcSEcCtD
Varenicline—Pruritus—Captopril—coronary artery disease	0.00017	0.000197	CcSEcCtD
Varenicline—Rash—Olmesartan—coronary artery disease	0.000169	0.000196	CcSEcCtD
Varenicline—Insomnia—Ramipril—coronary artery disease	0.000169	0.000196	CcSEcCtD
Varenicline—Dermatitis—Olmesartan—coronary artery disease	0.000169	0.000196	CcSEcCtD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	0.000169	0.00123	CbGpPWpGaD
Varenicline—Headache—Valsartan—coronary artery disease	0.000169	0.000196	CcSEcCtD
Varenicline—Diarrhoea—Telmisartan—coronary artery disease	0.000169	0.000196	CcSEcCtD
Varenicline—Infection—Lisinopril—coronary artery disease	0.000169	0.000196	CcSEcCtD
Varenicline—Headache—Olmesartan—coronary artery disease	0.000168	0.000195	CcSEcCtD
Varenicline—Shock—Lisinopril—coronary artery disease	0.000167	0.000194	CcSEcCtD
Varenicline—Asthenia—Perindopril—coronary artery disease	0.000167	0.000194	CcSEcCtD
Varenicline—Dyspnoea—Ramipril—coronary artery disease	0.000167	0.000193	CcSEcCtD
Varenicline—Vomiting—Niacin—coronary artery disease	0.000167	0.000193	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000167	0.000193	CcSEcCtD
Varenicline—Hypersensitivity—Furosemide—coronary artery disease	0.000167	0.000193	CcSEcCtD
Varenicline—Somnolence—Ramipril—coronary artery disease	0.000166	0.000193	CcSEcCtD
Varenicline—Thrombocytopenia—Lisinopril—coronary artery disease	0.000166	0.000193	CcSEcCtD
Varenicline—Dizziness—Trandolapril—coronary artery disease	0.000166	0.000192	CcSEcCtD
Varenicline—Tachycardia—Lisinopril—coronary artery disease	0.000166	0.000192	CcSEcCtD
Varenicline—Insomnia—Timolol—coronary artery disease	0.000166	0.000192	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL6—coronary artery disease	0.000166	0.00121	CbGpPWpGaD
Varenicline—Rash—Niacin—coronary artery disease	0.000166	0.000192	CcSEcCtD
Varenicline—Dermatitis—Niacin—coronary artery disease	0.000165	0.000192	CcSEcCtD
Varenicline—Dizziness—Enalapril—coronary artery disease	0.000165	0.000192	CcSEcCtD
Varenicline—Skin disorder—Lisinopril—coronary artery disease	0.000165	0.000191	CcSEcCtD
Varenicline—Dyspepsia—Ramipril—coronary artery disease	0.000165	0.000191	CcSEcCtD
Varenicline—Pruritus—Perindopril—coronary artery disease	0.000165	0.000191	CcSEcCtD
Varenicline—Headache—Niacin—coronary artery disease	0.000164	0.000191	CcSEcCtD
Varenicline—Vomiting—Pravastatin—coronary artery disease	0.000164	0.00019	CcSEcCtD
Varenicline—Hyperhidrosis—Lisinopril—coronary artery disease	0.000164	0.00019	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.000164	0.0012	CbGpPWpGaD
Varenicline—Diarrhoea—Captopril—coronary artery disease	0.000164	0.00019	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	0.000164	0.00119	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—CREB1—coronary artery disease	0.000163	0.00119	CbGpPWpGaD
Varenicline—Dyspnoea—Timolol—coronary artery disease	0.000163	0.000189	CcSEcCtD
Varenicline—Dizziness—Telmisartan—coronary artery disease	0.000163	0.000189	CcSEcCtD
Varenicline—Rash—Pravastatin—coronary artery disease	0.000163	0.000189	CcSEcCtD
Varenicline—Dermatitis—Pravastatin—coronary artery disease	0.000163	0.000189	CcSEcCtD
Varenicline—Decreased appetite—Ramipril—coronary artery disease	0.000163	0.000189	CcSEcCtD
Varenicline—Somnolence—Timolol—coronary artery disease	0.000163	0.000189	CcSEcCtD
Varenicline—Asthenia—Furosemide—coronary artery disease	0.000162	0.000188	CcSEcCtD
Varenicline—Headache—Pravastatin—coronary artery disease	0.000162	0.000188	CcSEcCtD
Varenicline—Anorexia—Lisinopril—coronary artery disease	0.000162	0.000188	CcSEcCtD
Varenicline—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000162	0.000187	CcSEcCtD
Varenicline—Fatigue—Ramipril—coronary artery disease	0.000161	0.000187	CcSEcCtD
Varenicline—Dyspepsia—Timolol—coronary artery disease	0.000161	0.000187	CcSEcCtD
Varenicline—Hypersensitivity—Losartan—coronary artery disease	0.000161	0.000186	CcSEcCtD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	0.000161	0.00117	CbGpPWpGaD
Varenicline—Nausea—Valsartan—coronary artery disease	0.00016	0.000186	CcSEcCtD
Varenicline—Pruritus—Furosemide—coronary artery disease	0.00016	0.000186	CcSEcCtD
Varenicline—Constipation—Ramipril—coronary artery disease	0.00016	0.000186	CcSEcCtD
Varenicline—Nausea—Olmesartan—coronary artery disease	0.00016	0.000185	CcSEcCtD
Varenicline—Vomiting—Trandolapril—coronary artery disease	0.00016	0.000185	CcSEcCtD
Varenicline—Diarrhoea—Perindopril—coronary artery disease	0.000159	0.000185	CcSEcCtD
Varenicline—Decreased appetite—Timolol—coronary artery disease	0.000159	0.000184	CcSEcCtD
Varenicline—Vomiting—Enalapril—coronary artery disease	0.000159	0.000184	CcSEcCtD
Varenicline—Hypotension—Lisinopril—coronary artery disease	0.000159	0.000184	CcSEcCtD
Varenicline—Dizziness—Captopril—coronary artery disease	0.000159	0.000184	CcSEcCtD
Varenicline—Rash—Trandolapril—coronary artery disease	0.000158	0.000183	CcSEcCtD
Varenicline—Dermatitis—Trandolapril—coronary artery disease	0.000158	0.000183	CcSEcCtD
Varenicline—Gastrointestinal disorder—Timolol—coronary artery disease	0.000158	0.000183	CcSEcCtD
Varenicline—Fatigue—Timolol—coronary artery disease	0.000158	0.000183	CcSEcCtD
Varenicline—Rash—Enalapril—coronary artery disease	0.000158	0.000183	CcSEcCtD
Varenicline—Dermatitis—Enalapril—coronary artery disease	0.000157	0.000183	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000157	0.00115	CbGpPWpGaD
Varenicline—Headache—Trandolapril—coronary artery disease	0.000157	0.000182	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000157	0.00115	CbGpPWpGaD
Varenicline—Vomiting—Telmisartan—coronary artery disease	0.000157	0.000182	CcSEcCtD
Varenicline—Asthenia—Losartan—coronary artery disease	0.000157	0.000182	CcSEcCtD
Varenicline—Headache—Enalapril—coronary artery disease	0.000157	0.000182	CcSEcCtD
Varenicline—Pain—Timolol—coronary artery disease	0.000157	0.000181	CcSEcCtD
Varenicline—Nausea—Niacin—coronary artery disease	0.000156	0.000181	CcSEcCtD
Varenicline—Rash—Telmisartan—coronary artery disease	0.000155	0.00018	CcSEcCtD
Varenicline—Dermatitis—Telmisartan—coronary artery disease	0.000155	0.00018	CcSEcCtD
Varenicline—Diarrhoea—Furosemide—coronary artery disease	0.000155	0.000179	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000155	0.000179	CcSEcCtD
Varenicline—Pruritus—Losartan—coronary artery disease	0.000154	0.000179	CcSEcCtD
Varenicline—Headache—Telmisartan—coronary artery disease	0.000154	0.000179	CcSEcCtD
Varenicline—Feeling abnormal—Ramipril—coronary artery disease	0.000154	0.000179	CcSEcCtD
Varenicline—Dizziness—Perindopril—coronary artery disease	0.000154	0.000178	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—MAPK1—coronary artery disease	0.000154	0.00112	CbGpPWpGaD
Varenicline—Insomnia—Lisinopril—coronary artery disease	0.000154	0.000178	CcSEcCtD
Varenicline—Nausea—Pravastatin—coronary artery disease	0.000154	0.000178	CcSEcCtD
Varenicline—Gastrointestinal pain—Ramipril—coronary artery disease	0.000153	0.000177	CcSEcCtD
Varenicline—Vomiting—Captopril—coronary artery disease	0.000152	0.000177	CcSEcCtD
Varenicline—Dyspnoea—Lisinopril—coronary artery disease	0.000151	0.000175	CcSEcCtD
Varenicline—Rash—Captopril—coronary artery disease	0.000151	0.000175	CcSEcCtD
Varenicline—Dermatitis—Captopril—coronary artery disease	0.000151	0.000175	CcSEcCtD
Varenicline—Somnolence—Lisinopril—coronary artery disease	0.000151	0.000175	CcSEcCtD
Varenicline—Feeling abnormal—Timolol—coronary artery disease	0.000151	0.000175	CcSEcCtD
Varenicline—Headache—Captopril—coronary artery disease	0.00015	0.000174	CcSEcCtD
Varenicline—Gastrointestinal pain—Timolol—coronary artery disease	0.00015	0.000173	CcSEcCtD
Varenicline—Dizziness—Furosemide—coronary artery disease	0.00015	0.000173	CcSEcCtD
Varenicline—Dyspepsia—Lisinopril—coronary artery disease	0.000149	0.000173	CcSEcCtD
Varenicline—Diarrhoea—Losartan—coronary artery disease	0.000149	0.000173	CcSEcCtD
Varenicline—Nausea—Trandolapril—coronary artery disease	0.000149	0.000173	CcSEcCtD
Varenicline—Urticaria—Ramipril—coronary artery disease	0.000149	0.000172	CcSEcCtD
Varenicline—Nausea—Enalapril—coronary artery disease	0.000148	0.000172	CcSEcCtD
Varenicline—Vomiting—Perindopril—coronary artery disease	0.000148	0.000172	CcSEcCtD
Varenicline—Abdominal pain—Ramipril—coronary artery disease	0.000148	0.000172	CcSEcCtD
Varenicline—Body temperature increased—Ramipril—coronary artery disease	0.000148	0.000172	CcSEcCtD
Varenicline—Decreased appetite—Lisinopril—coronary artery disease	0.000148	0.000171	CcSEcCtD
Varenicline—Rash—Perindopril—coronary artery disease	0.000147	0.00017	CcSEcCtD
Varenicline—Dermatitis—Perindopril—coronary artery disease	0.000147	0.00017	CcSEcCtD
Varenicline—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000147	0.00017	CcSEcCtD
Varenicline—Nausea—Telmisartan—coronary artery disease	0.000146	0.00017	CcSEcCtD
Varenicline—Fatigue—Lisinopril—coronary artery disease	0.000146	0.00017	CcSEcCtD
Varenicline—Headache—Perindopril—coronary artery disease	0.000146	0.000169	CcSEcCtD
Varenicline—Urticaria—Timolol—coronary artery disease	0.000145	0.000169	CcSEcCtD
Varenicline—Constipation—Lisinopril—coronary artery disease	0.000145	0.000168	CcSEcCtD
Varenicline—Pain—Lisinopril—coronary artery disease	0.000145	0.000168	CcSEcCtD
Varenicline—Body temperature increased—Timolol—coronary artery disease	0.000145	0.000168	CcSEcCtD
Varenicline—Abdominal pain—Timolol—coronary artery disease	0.000145	0.000168	CcSEcCtD
Varenicline—Dizziness—Losartan—coronary artery disease	0.000144	0.000167	CcSEcCtD
Varenicline—Vomiting—Furosemide—coronary artery disease	0.000144	0.000167	CcSEcCtD
Varenicline—Rash—Furosemide—coronary artery disease	0.000143	0.000165	CcSEcCtD
Varenicline—Dermatitis—Furosemide—coronary artery disease	0.000143	0.000165	CcSEcCtD
Varenicline—Nausea—Captopril—coronary artery disease	0.000142	0.000165	CcSEcCtD
Varenicline—Headache—Furosemide—coronary artery disease	0.000142	0.000164	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—TNF—coronary artery disease	0.00014	0.00102	CbGpPWpGaD
Varenicline—Feeling abnormal—Lisinopril—coronary artery disease	0.00014	0.000162	CcSEcCtD
Varenicline—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000139	0.000161	CcSEcCtD
Varenicline—Vomiting—Losartan—coronary artery disease	0.000139	0.000161	CcSEcCtD
Varenicline—Nausea—Perindopril—coronary artery disease	0.000138	0.00016	CcSEcCtD
Varenicline—Hypersensitivity—Ramipril—coronary artery disease	0.000138	0.00016	CcSEcCtD
Varenicline—Rash—Losartan—coronary artery disease	0.000138	0.00016	CcSEcCtD
Varenicline—Dermatitis—Losartan—coronary artery disease	0.000138	0.000159	CcSEcCtD
Varenicline—Headache—Losartan—coronary artery disease	0.000137	0.000159	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—MAPK1—coronary artery disease	0.000135	0.000987	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—IL6—coronary artery disease	0.000135	0.000986	CbGpPWpGaD
Varenicline—Urticaria—Lisinopril—coronary artery disease	0.000135	0.000156	CcSEcCtD
Varenicline—Hypersensitivity—Timolol—coronary artery disease	0.000135	0.000156	CcSEcCtD
Varenicline—Nausea—Furosemide—coronary artery disease	0.000134	0.000156	CcSEcCtD
Varenicline—Asthenia—Ramipril—coronary artery disease	0.000134	0.000156	CcSEcCtD
Varenicline—Abdominal pain—Lisinopril—coronary artery disease	0.000134	0.000156	CcSEcCtD
Varenicline—Body temperature increased—Lisinopril—coronary artery disease	0.000134	0.000156	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	0.000133	0.000973	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—CREB1—coronary artery disease	0.000133	0.000972	CbGpPWpGaD
Varenicline—Pruritus—Ramipril—coronary artery disease	0.000132	0.000154	CcSEcCtD
Varenicline—Asthenia—Timolol—coronary artery disease	0.000131	0.000152	CcSEcCtD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	0.000131	0.000955	CbGpPWpGaD
Varenicline—Nausea—Losartan—coronary artery disease	0.00013	0.00015	CcSEcCtD
Varenicline—Pruritus—Timolol—coronary artery disease	0.00013	0.00015	CcSEcCtD
Varenicline—Diarrhoea—Ramipril—coronary artery disease	0.000128	0.000148	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	0.000127	0.000928	CbGpPWpGaD
Varenicline—Diarrhoea—Timolol—coronary artery disease	0.000125	0.000145	CcSEcCtD
Varenicline—Hypersensitivity—Lisinopril—coronary artery disease	0.000125	0.000145	CcSEcCtD
Varenicline—Dizziness—Ramipril—coronary artery disease	0.000124	0.000144	CcSEcCtD
Varenicline—Asthenia—Lisinopril—coronary artery disease	0.000122	0.000141	CcSEcCtD
Varenicline—Dizziness—Timolol—coronary artery disease	0.000121	0.00014	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—MAPK1—coronary artery disease	0.000121	0.00088	CbGpPWpGaD
Varenicline—Pruritus—Lisinopril—coronary artery disease	0.00012	0.000139	CcSEcCtD
Varenicline—Vomiting—Ramipril—coronary artery disease	0.000119	0.000138	CcSEcCtD
Varenicline—Rash—Ramipril—coronary artery disease	0.000118	0.000137	CcSEcCtD
Varenicline—Dermatitis—Ramipril—coronary artery disease	0.000118	0.000137	CcSEcCtD
Varenicline—Headache—Ramipril—coronary artery disease	0.000117	0.000136	CcSEcCtD
Varenicline—Vomiting—Timolol—coronary artery disease	0.000116	0.000135	CcSEcCtD
Varenicline—Diarrhoea—Lisinopril—coronary artery disease	0.000116	0.000135	CcSEcCtD
Varenicline—Rash—Timolol—coronary artery disease	0.000115	0.000134	CcSEcCtD
Varenicline—Dermatitis—Timolol—coronary artery disease	0.000115	0.000134	CcSEcCtD
Varenicline—Headache—Timolol—coronary artery disease	0.000115	0.000133	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—TNF—coronary artery disease	0.000114	0.000834	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL6—coronary artery disease	0.000113	0.000825	CbGpPWpGaD
Varenicline—Dizziness—Lisinopril—coronary artery disease	0.000112	0.00013	CcSEcCtD
Varenicline—Nausea—Ramipril—coronary artery disease	0.000111	0.000129	CcSEcCtD
Varenicline—Nausea—Timolol—coronary artery disease	0.000109	0.000126	CcSEcCtD
Varenicline—Vomiting—Lisinopril—coronary artery disease	0.000108	0.000125	CcSEcCtD
Varenicline—Rash—Lisinopril—coronary artery disease	0.000107	0.000124	CcSEcCtD
Varenicline—Dermatitis—Lisinopril—coronary artery disease	0.000107	0.000124	CcSEcCtD
Varenicline—Headache—Lisinopril—coronary artery disease	0.000106	0.000123	CcSEcCtD
Varenicline—Nausea—Lisinopril—coronary artery disease	0.000101	0.000117	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—MAPK1—coronary artery disease	9.84e-05	0.000718	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—MAPK1—coronary artery disease	9.74e-05	0.000711	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—MAPK1—coronary artery disease	9.25e-05	0.000674	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL6—coronary artery disease	9.22e-05	0.000673	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—MAPK1—coronary artery disease	7.54e-05	0.00055	CbGpPWpGaD
Varenicline—CHRNA4—autonomic nervous system—coronary artery disease	3.13e-05	0.331	CbGeAlD
Varenicline—CHRNB2—myocardium—coronary artery disease	1.5e-05	0.158	CbGeAlD
Varenicline—CHRNB2—heart—coronary artery disease	1.05e-05	0.11	CbGeAlD
Varenicline—CHRNB2—blood—coronary artery disease	7.8e-06	0.0824	CbGeAlD
Varenicline—CHRNA7—heart—coronary artery disease	6.63e-06	0.07	CbGeAlD
Varenicline—CHRNA7—cardiovascular system—coronary artery disease	6.25e-06	0.066	CbGeAlD
Varenicline—CHRNA4—cardiovascular system—coronary artery disease	6.17e-06	0.0652	CbGeAlD
Varenicline—CHRFAM7A—blood—coronary artery disease	6.12e-06	0.0647	CbGeAlD
Varenicline—CHRNA7—blood—coronary artery disease	4.94e-06	0.0522	CbGeAlD
